LIFEVANTAGE CORP Long-Lived Assets
LIFEVANTAGE CORP (LFVN) had Long-Lived Assets of $23.10 thousand as of 2026-06-30, per its 10-K filed 2026-08-27.
Financial Statements › Notes › Segment Reporting
us-gaap:NoncurrentAssets · last filed 2026-08-27
- 2026-06-30: Long-Lived Assets $23.10K.
- 2026-03-31: Long-Lived Assets $22.10K.
- 2025-12-31: Long-Lived Assets $21.89M.
- 2025-09-30: Long-Lived Assets $16.29M.
| Period end | Long-Lived Assets | Long-Lived Assets as first filed |
|---|---|---|
| 2026-06-30 | $23.10K 10-K · filed 2026-08-27 | |
| 2026-03-31 | $22.10K 10-Q · filed 2026-05-06 | |
| 2025-12-31 | $21.89M 10-Q · filed 2026-02-04 | |
| 2025-09-30 | $16.29M 10-Q · filed 2025-11-04 | |
| 2025-06-30 | $20.82K 10-K · filed 2026-08-27 | $20.82M 10-K · filed 2025-09-04 |
| 2024-06-30 | $21.75M 10-K · filed 2025-09-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |